Sanofi India Limited (SANOFI.NS)
INR 6082.6
(-0.65%)
INR 6082.6
(-0.65%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 261.78 INR | -2.85% |
| 2022 | 269.47 INR | -34.29% |
| 2021 | 410.06 INR | 97.73% |
| 2020 | 207.38 INR | 15.31% |
| 2019 | 179.85 INR | 8.83% |
| 2018 | 165.26 INR | 16.59% |
| 2017 | 141.74 INR | 7.31% |
| 2016 | 132.09 INR | -5.37% |
| 2015 | 139.59 INR | 21.96% |
| 2014 | 114.46 INR | -0.59% |
| 2013 | 115.14 INR | 50.1% |
| 2012 | 76.71 INR | -7.59% |
| 2011 | 83.01 INR | -17.15% |
| 2010 | 100.19 INR | 46.58% |
| 2009 | 68.35 INR | -5.28% |
| 2008 | 72.16 INR | 15.07% |
| 2007 | 62.71 INR | -14.69% |
| 2006 | 73.51 INR | 16.68% |
| 2005 | 63.00 INR | -2.3% |
| 2004 | 64.48 INR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 59.31 INR | -0.8% |
| 2024 Q2 | 44.81 INR | -24.45% |
| 2023 Q1 | 82.67 INR | 45.44% |
| 2023 FY | - INR | -2.85% |
| 2023 Q2 | 53.36 INR | -35.45% |
| 2023 Q4 | 59.79 INR | -9.35% |
| 2023 Q3 | 65.96 INR | 23.61% |
| 2022 FY | - INR | -34.29% |
| 2022 Q2 | 52.28 INR | -49.49% |
| 2022 Q3 | 56.84 INR | 8.72% |
| 2022 Q4 | 56.84 INR | 0.0% |
| 2022 Q1 | 103.51 INR | 163.72% |
| 2021 Q1 | 63.35 INR | 18.61% |
| 2021 Q3 | 230.04 INR | 197.13% |
| 2021 Q4 | 39.25 INR | -82.94% |
| 2021 Q2 | 77.42 INR | 22.21% |
| 2021 FY | - INR | 97.73% |
| 2020 FY | - INR | 15.31% |
| 2020 Q4 | 53.41 INR | -7.45% |
| 2020 Q3 | 57.71 INR | -2.48% |
| 2020 Q2 | 59.18 INR | 59.6% |
| 2020 Q1 | 37.08 INR | -12.24% |
| 2019 Q4 | 42.25 INR | -23.13% |
| 2019 Q1 | 40.34 INR | 17.0% |
| 2019 Q2 | 42.29 INR | 4.83% |
| 2019 Q3 | 54.96 INR | 29.96% |
| 2019 FY | - INR | 8.83% |
| 2018 Q2 | 43.30 INR | 20.71% |
| 2018 Q4 | 34.48 INR | -33.47% |
| 2018 FY | - INR | 16.59% |
| 2018 Q1 | 35.87 INR | 8.53% |
| 2018 Q3 | 51.83 INR | 19.7% |
| 2017 Q3 | 50.57 INR | 57.83% |
| 2017 Q2 | 32.04 INR | 22.81% |
| 2017 Q1 | 26.09 INR | 13.98% |
| 2017 FY | - INR | 7.31% |
| 2017 Q4 | 33.05 INR | -34.65% |
| 2016 Q4 | 22.89 INR | -36.49% |
| 2016 FY | - INR | -5.37% |
| 2016 Q3 | 36.04 INR | -3.71% |
| 2016 Q2 | 37.43 INR | 4.23% |
| 2016 Q1 | 35.91 INR | -31.06% |
| 2015 Q3 | 31.52 INR | 13.14% |
| 2015 FY | - INR | 21.96% |
| 2015 Q4 | 52.09 INR | 65.26% |
| 2015 Q1 | 28.04 INR | 149.69% |
| 2015 Q2 | 27.86 INR | -0.64% |
| 2014 Q2 | 24.96 INR | 11.03% |
| 2014 Q3 | 26.93 INR | 7.89% |
| 2014 FY | - INR | -0.59% |
| 2014 Q4 | 11.23 INR | -58.3% |
| 2014 Q1 | 22.48 INR | -22.96% |
| 2013 Q4 | 29.18 INR | -12.71% |
| 2013 Q2 | 22.27 INR | 15.51% |
| 2013 Q1 | 19.28 INR | -0.82% |
| 2013 FY | - INR | 50.1% |
| 2013 Q3 | 33.43 INR | 50.11% |
| 2012 Q3 | 22.30 INR | 26.63% |
| 2012 Q4 | 19.44 INR | -12.83% |
| 2012 Q2 | 17.61 INR | 1.03% |
| 2012 Q1 | 17.43 INR | -26.42% |
| 2012 FY | - INR | -7.59% |
| 2011 Q2 | 21.61 INR | 0.0% |
| 2011 Q4 | 23.69 INR | -0.59% |
| 2011 Q3 | 23.83 INR | 10.27% |
| 2011 FY | - INR | -17.15% |
| 2010 FY | - INR | 46.58% |
| 2009 FY | - INR | -5.28% |
| 2008 FY | - INR | 15.07% |
| 2007 FY | - INR | -14.69% |
| 2006 FY | - INR | 16.68% |
| 2005 FY | - INR | -2.3% |
| 2004 FY | - INR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Abbott India Limited | 565.30 INR | 53.692% |
| Cipla Limited | 51.05 INR | -412.791% |
| Gland Pharma Limited | 46.90 INR | -458.166% |
| GlaxoSmithKline Pharmaceuticals Limited | 34.83 INR | -651.593% |
| Kopran Limited | 10.57 INR | -2376.632% |
| Marksans Pharma Limited | 6.92 INR | -3682.948% |
| NGL Fine-Chem Limited | 66.88 INR | -291.417% |
| Pfizer Limited | 120.51 INR | -117.227% |
| SMS Pharmaceuticals Limited | 5.89 INR | -4344.482% |
| TTK Healthcare Limited | 44.47 INR | -488.667% |